Advertisement
UK markets close in 3 hours 33 minutes
  • FTSE 100

    7,952.81
    +20.83 (+0.26%)
     
  • FTSE 250

    19,848.77
    +38.11 (+0.19%)
     
  • AIM

    743.15
    +1.04 (+0.14%)
     
  • GBP/EUR

    1.1698
    +0.0029 (+0.25%)
     
  • GBP/USD

    1.2634
    -0.0004 (-0.03%)
     
  • Bitcoin GBP

    55,795.54
    +289.11 (+0.52%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • DOW

    39,760.08
    +477.75 (+1.22%)
     
  • CRUDE OIL

    82.69
    +1.34 (+1.65%)
     
  • GOLD FUTURES

    2,228.50
    +15.80 (+0.71%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,479.03
    +1.94 (+0.01%)
     
  • CAC 40

    8,220.95
    +16.14 (+0.20%)
     

Fitch affirms Aegon's Zest VIF notes at 'A'

Nov 15 (Reuters) - (The following statement was released by the rating agency)

Fitch Ratings has affirmed Scottish Equitable plc's (Scottish Equitable) GBP250m value of in-force (VIF) securitisation fixed-rate loan notes due 2023 at 'A'.

The affirmation reflects the transaction's performance, which is in line with Fitch's expectations.

The transaction, referred to as 'Zest', is a securitisation of the future profits arising from a book of unit-linked pensions business. Scottish Equitable is the principal UK subsidiary of Aegon N.V (NYSE: AEB - news) . (Aegon; A/Negative).

The issued notes do not benefit from a financial guarantee insurance policy and there is no recourse to Scottish Equitable.

ADVERTISEMENT

Although the transaction is a contingent loan with no recourse to the sponsor, the notes' rating has been established under Fitch's Corporate Finance methodology. This is because in Fitch's opinion, the transaction has no significant structured finance elements.

KEY RATING DRIVERS

The rating is based on analysis of the transaction documents, the volatility of underlying profit sources, and analysis of the transaction's expected cash flows. Fitch's rating process at the outset of the transaction included a review of the embedded value methodology, assumptions and actuarial model developed by Scottish Equitable. Tillinghast, an actuarial consulting firm of Towers Watson, independently reviewed the model and the assumptions used. These assumptions are updated on an annual basis by Aegon (Xetra: AEND.DE - news) and reviewed by Fitch.

The transaction currently has GBP15m of principal outstanding. As the transaction generates approximately GBP60m of free surplus annually, Fitch expects the transaction to be fully repaid in July 2014, unless there is an extraordinary event outside of the 'A' range.

RATING SENSITIVITIES

Zest could be downgraded if, in Fitch's opinion, future cash flows are unlikely to be sufficient to cover the repayment of the loan and interest payments under a 'A' stressed scenario or if the transaction underperforms by more than GBP15m in one year or GBP30m on a cumulative basis. The transaction could also be downgraded if Fitch's opinion of Scottish Equitable or Aegon's credit quality deteriorates.